Literature DB >> 29873060

Milligram scale production of potent recombinant small interfering RNAs in Escherichia coli.

Guneet Kaur1,2, Hung-Chi Cheung1, Wei Xu1,3, Jun Vic Wong1, For Fan Chan1, Yingxue Li1,3, Larry McReynolds4, Linfeng Huang1,3.   

Abstract

Small interfering RNAs (siRNAs) are invaluable research tools for studying gene functions in mammalian cells. siRNAs are mainly produced by chemical synthesis or by enzymatic digestion of double-stranded RNA (dsRNA) produced in vitro. Recently, bacterial cells, engineered with ectopic plant viral siRNA binding protein p19, have enabled the production of "recombinant" siRNAs (pro-siRNAs). Here, we describe an optimized methodology for the production of milligram amount of highly potent recombinant pro-siRNAs from Escherichia coli cells. We first optimized bacterial culture medium and tested new designs of pro-siRNA production plasmid. Through the exploration of multiple pro-siRNA related factors, including the expression of p19 protein, (dsRNA) generation method, and the level of RNase III, we developed an optimal pro-siRNA production plasmid. Together with a high-cell density fed-batch fermentation method in a bioreactor, we have achieved a yield of ~10 mg purified pro-siRNA per liter of bacterial culture. The pro-siRNAs produced by the optimized method can achieve high efficiency of gene silencing when used at low nanomolar concentrations. This new method enables fast, economical, and renewable production of pure and highly potent bioengineered pro-siRNAs at the milligram level. Our study also provides important insights into the strategies for optimizing the production of RNA products in bacteria, which is an under-explored field.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  RNA interference (RNAi); RNAi therapeutics; fermentation; pro-siRNA; small interfering RNA (siRNA)

Mesh:

Substances:

Year:  2018        PMID: 29873060     DOI: 10.1002/bit.26740

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  3 in total

1.  Saccharomyces cerevisiae (Baker's Yeast) as an Interfering RNA Expression and Delivery System.

Authors:  Molly Duman-Scheel
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

2.  Assessment of recombinant protein production in E. coli with Time-Gated Surface Enhanced Raman Spectroscopy (TG-SERS).

Authors:  Martin Kögler; Jaakko Itkonen; Tapani Viitala; Marco G Casteleijn
Journal:  Sci Rep       Date:  2020-02-12       Impact factor: 4.379

3.  Tombusvirus p19 Captures RNase III-Cleaved Double-Stranded RNAs Formed by Overlapping Sense and Antisense Transcripts in Escherichia coli.

Authors:  Linfeng Huang; Padraig Deighan; Jingmin Jin; Yingxue Li; Hung-Chi Cheung; Elaine Lee; Shirley S Mo; Heather Hoover; Sahar Abubucker; Nancy Finkel; Larry McReynolds; Ann Hochschild; Judy Lieberman
Journal:  mBio       Date:  2020-06-09       Impact factor: 7.867

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.